Parag Kale

859 total citations
30 papers, 346 citations indexed

About

Parag Kale is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Parag Kale has authored 30 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in Parag Kale's work include Mechanical Circulatory Support Devices (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers) and Transplantation: Methods and Outcomes (6 papers). Parag Kale is often cited by papers focused on Mechanical Circulatory Support Devices (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers) and Transplantation: Methods and Outcomes (6 papers). Parag Kale collaborates with scholars based in United States, United Kingdom and Italy. Parag Kale's co-authors include Shelley Hall, Brian Lima, Gonzalo V. Gonzalez‐Stawinski, Johannes J. Kuiper, Sandra Carey, Ronald Witteles, Ranjan Ray, Dipanjan Banerjee, Richard Ha and Joost Felius and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Parag Kale

29 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parag Kale United States 8 195 157 109 87 68 30 346
Matthias Helmschrott Germany 13 232 1.2× 79 0.5× 77 0.7× 148 1.7× 3 0.0× 27 374
Jan Dominik Czechia 9 97 0.5× 30 0.2× 36 0.3× 173 2.0× 26 0.4× 52 327
Rawa Arif Germany 13 194 1.0× 94 0.6× 52 0.5× 221 2.5× 77 1.1× 41 461
Georg Schlachtenberger Germany 9 88 0.5× 63 0.4× 21 0.2× 95 1.1× 37 0.5× 49 257
Brunilda Alushi Germany 11 144 0.7× 78 0.5× 40 0.4× 412 4.7× 52 0.8× 39 538
Joseph Campbell United States 7 130 0.7× 59 0.4× 21 0.2× 57 0.7× 38 0.6× 14 198
Guangqi Qin Sweden 10 172 0.9× 102 0.6× 36 0.3× 34 0.4× 23 0.3× 17 271
Toyoki Fukuda Japan 8 162 0.8× 53 0.3× 18 0.2× 155 1.8× 24 0.4× 20 305
Joonho Jung South Korea 11 190 1.0× 91 0.6× 27 0.2× 55 0.6× 68 1.0× 25 373
John Sirak United States 11 96 0.5× 40 0.3× 17 0.2× 144 1.7× 29 0.4× 21 324

Countries citing papers authored by Parag Kale

Since Specialization
Citations

This map shows the geographic impact of Parag Kale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parag Kale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parag Kale more than expected).

Fields of papers citing papers by Parag Kale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parag Kale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parag Kale. The network helps show where Parag Kale may publish in the future.

Co-authorship network of co-authors of Parag Kale

This figure shows the co-authorship network connecting the top 25 collaborators of Parag Kale. A scholar is included among the top collaborators of Parag Kale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parag Kale. Parag Kale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Pavía, Pablo, Martha Grogan, Parag Kale, et al.. (2024). Impact of Vutrisiran on Exploratory Cardiac Parameters in Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy. European Journal of Heart Failure. 26(2). 397–410. 29 indexed citations
2.
Shah, Zubair, Laura Obici, Parag Kale, et al.. (2024). Impact Of Patisiran On Health Status And Quality Of Life In Patients With Transthyretin Cardiac Amyloidosis. Journal of Cardiac Failure. 30(1). 134–134.
3.
Alam, Amit, Joost Felius, Sandra Carey, et al.. (2024). Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation. Transplant Immunology. 83. 102009–102009. 1 indexed citations
4.
Kale, Parag, Matthew J. Maurer, Marianna Fontana, et al.. (2023). Exploratory Analyses From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Attr Amyloidosis With Cardiomyopathy. Journal of Cardiac Failure. 29(4). 552–552. 2 indexed citations
5.
Kale, Parag, et al.. (2023). Successful Recovery From West Nile Virus Meningitis In Heart Transplant Recipient. Journal of Cardiac Failure. 29(4). 629–629. 1 indexed citations
6.
Wencker, Detlef, et al.. (2022). The man in the mirror: Biventricular device implantation in a patient with dextrocardia with situs inversus totalis. HeartRhythm Case Reports. 8(11). 790–792. 1 indexed citations
7.
Afzal, Aasim, Tariq Nisar, Aaron Y. Kluger, et al.. (2022). Trends in Hospital Admissions for Systolic and Diastolic Heart Failure in the United States Between 2004 and 2017. The American Journal of Cardiology. 171. 99–104. 7 indexed citations
8.
Carey, Sandra, et al.. (2022). Incorporating Palliative Care as Standard Practice in Heart Transplant Rejection Therapy. The Journal of Heart and Lung Transplantation. 41(4). S349–S349. 1 indexed citations
10.
Tecson, Kristen M., et al.. (2019). Community-Acquired Acute Kidney Injury as a Risk Factor of de novo Heart Failure Hospitalization. Cardiorenal Medicine. 9(4). 252–260. 8 indexed citations
11.
Afzal, Aasim, Tariq Nisar, Aaron Y. Kluger, et al.. (2019). EFFECT OF PREOPERATIVE RENAL DYSFUNCTION ON COST AND OUTCOMES IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT IN THE UNITED STATES BETWEEN 2004-2014. Journal of the American College of Cardiology. 73(9). 1264–1264. 8 indexed citations
12.
Joseph, Susan, Brian Lima, Gonzalo V. Gonzalez‐Stawinski, et al.. (2018). Donor predicted heart mass as predictor of primary graft dysfunction. The Journal of Heart and Lung Transplantation. 37(7). 826–835. 42 indexed citations
13.
Afzal, Aasim, Tariq Nisar, Aaron Y. Kluger, et al.. (2018). Abstract 17241: National Trends in Systolic and Diastolic Heart Failure From 2004 to 2014. Circulation. 138(Suppl_1). 1 indexed citations
14.
Tecson, Kristen M., Anupama Vasudevan, Susan Joseph, et al.. (2017). Validation of Peripherally Inserted Central Catheter-Derived Fick Cardiac Outputs in Patients with Heart Failure. The American Journal of Cardiology. 121(1). 50–54. 4 indexed citations
15.
Joseph, Susan, et al.. (2017). Arrhythmogenic Right Ventricular Dysplasia: An Under-recognized Form of Inherited Cardiomyopathy. Reviews in Cardiovascular Medicine. 18(1). 37–43. 1 indexed citations
16.
Lima, Brian, Shelley Hall, Kristen M. Tecson, et al.. (2017). Postoperative Vasoplegia Is Strongly Associated with Short and Long Term Outcomes in Patients Receiving Left Ventricular Assist Device (LVAD) Therapy. The Journal of Heart and Lung Transplantation. 36(4). S84–S85. 1 indexed citations
17.
Lima, Brian, Parag Kale, Gonzalo V. Gonzalez‐Stawinski, et al.. (2016). Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device. The American Journal of Cardiology. 117(10). 1622–1628. 92 indexed citations
18.
Davis, Margot K., Parag Kale, Michaela Liedtke, et al.. (2015). Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era. American Journal of Transplantation. 15(3). 650–658. 63 indexed citations
19.
Ray, Ranjan, Parag Kale, Richard Ha, & Dipanjan Banerjee. (2014). Treatment of Left Ventricular Assist Device–Associated Arteriovenous Malformations with Thalidomide. ASAIO Journal. 60(4). 482–483. 34 indexed citations
20.
Kale, Parag & James C. Fang. (2008). Devices in acute heart failure. Critical Care Medicine. 36(Suppl). S121–S128. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026